Atlas FDA

SUPERA PERIPHERAL STENT SYSTEM

FDA premarket approval P120020 · decided 2014-03-28

Approval details

PMA number
P120020
Trade name
SUPERA PERIPHERAL STENT SYSTEM
Generic name
STENT, SUPERFICIAL FEMORAL ARTERY
Applicant
Abbott Vascular (Idef Technologies Inc)
Date received
2012-11-16
Decision date
2014-03-28
Days to decision
497 days
Decision code
APPR
Product code
NIP
Advisory committee
Cardiovascular
Expedited review
No
Location
Santa Clara, CA
Statement
APPROVAL FOR THE SUPERA® PERIPHERAL STENT SYSTEM. THIS DEVICE IS INDICATED TO IMPROVE LUMINAL DIAMETER IN THE TREATMENT OF PATIENTS WITH SYMPTOMATIC DE NOVO OR RESTENOTIC NATIVE LESIONS OR OCCLUSIONS OF THE SUPERFICIAL FEMORAL ARTERY (SFA) AND/OR PROXIMAL POPLITEAL ARTERY, WITH REFERENCE VESSEL DIAMETERS OF 4.0 TO 6.5 MM, AND LESION LENGTHS UP TO 140 MM.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.